Active Ingredient: GRANISETRON
Proprietary Name: SANCUSO
Dosage Form; Route of Administration: FILM, EXTENDED RELEASE; TRANSDERMAL
Strength: 3.1MG/24HR
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N022198
Product Number: 001
Approval Date: Sep 12, 2008
Applicant Holder Full Name: CUMBERLAND PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
